Ferrotran.

[pjoshea13]

"December 24, 2019 — SPL Medical announced today that the first patient has been successfully diagnosed with suspected lymph node metastases of prostate cancer with Ferrotran (Ferumoxtran) at the University Hospital Zurich. This follows approval (Sonderbewilligung acc. to Swiss AMBV) by Swissmedic to Universitätsspital Zurich, Institut für Diagnostische und Interventionelle Radiologie, for restricted use of Ferrotran under a compassionate use program. Ferrotran (Ferumoxtran) is a novel contrast agent for use in MRI (magnetic resonance imaging) developed for the detection of lymph node metastases of prostate cancer. It is the first contrast agent for the use in MRI that is able to identify metastases as small as 1.5 mm. The rise of prostate specific antigen (PSA) is often the first symptom of suspected recurrent lymph node metastases. Being able to detect small metastases in prostate cancer early enough should enable a better chance of successful treatment."

itnonline.com/content/spl-m...

-Patrick

[GP24]

I suggest a new definition of oligometastatic prostate cancer. You are oligometastatic as long as you have no more than:

3 lesions with CT/bone scan

5 lesions with Axumin PET scan

10 lesions with PSMA PET/CT

15 lesions with Ferrotran

[cesces in reply to GP24]

I think that disregards the basis for why the classification works.

[cigafred]

Sounds very similar to Combidex/nano-iron MRI as offered at Radboud, the Netherlands.